็›้…ธๆ™ฎๆ‹‰ๅ…‹็ดข็ผ“้‡Š็‰‡ ็‰‡ๅ‰‚ 0.75mg

ืžื“ื™ื ื”: ืกื™ืŸ

ืฉืคื”: ืกื™ื ื™ืช

ืžืงื•ืจ: CFDA (่ฏ็›‘ๅฑ€ - ไธญๅ›ฝ้ฃŸๅ“ๅ’Œ่ฏ็‰ฉ็ฎก็†ๅฑ€)

ืงื ื” ืืช ื–ื”

ื–ืžื™ืŸ ืž:

Boehringer Ingelheim International GmbH

INN (ืฉื ื‘ื™ื ืœืื•ืžื™):

Pramipexole Dihydrochloride Sustained Release Tablets

ื›ืžื•ืช:

0.75mg

ื˜ื•ืคืก ืคืจืฆื‘ื˜ื™ื•ืช:

็‰‡ๅ‰‚

ื™ื—ื™ื“ื•ืช ื‘ืืจื™ื–ื”:

10็‰‡/็›’ใ€30็‰‡/็›’ใ€100็‰‡/็›’

ืชื•ืฆืจืช:

Boehringer Ingelheim Pharma GmbH & Co. KG

ืชืืจื™ืš ืื™ืฉื•ืจ:

2015-02-09

ื—ื™ืคื•ืฉ ื”ืชืจืื•ืช ื”ืงืฉื•ืจื•ืช ืœืžื•ืฆืจ ื–ื”